Tango Therapeutics, Inc. · NASDAQ:TNGX
Nextech Crossover I GP S.a. r.l. reported a 5.10% stake in Tango Therapeutics, Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Nextech Crossover I GP S.a. r.l. reported a 5.10% stake in Tango Therapeutics, Inc., 7,266,081 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 5.10%
- Shares
- 7,266,081
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Nextech Crossover I GP S.a. r.l. | 5.10% | 7,266,081 |
| Nextech Crossover I SCSp | 5.10% | 7,266,081 |
| Ian Charoub | 5.10% | 7,266,081 |
| Costas Constantinides | 5.10% | 7,266,081 |
| Rocco Sgobbo | 5.10% | 7,266,081 |
Source
Related
- Tango Therapeutics, Inc.
- Nextech Crossover I GP S.a. r.l.
- Tango Therapeutics, Inc. shareholders
- Schedule 13G/A · Nextech Crossover I GP S.a. r.l. · Aug 14, 2026
- Form 4 · Crystal Adam · Oct 5, 2026
- Form 4 · Newcomb Jessica · Sep 24, 2026
- Form 4 · Crystal Adam · Sep 3, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · Aug 14, 2026
- Schedule 13G · Goldman Sachs Group Inc · Aug 14, 2026